Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Roberts

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Blood|June 25, 2025
Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndromeNatalina Elliott, Neha Bhatnagar, Gemma Buck, et al.
Blood|November 22, 2012
Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myelomaAristeidis Chaidos, Chris P Barnes, Gillian Cowan, et al.
Blood|July 29, 2025
Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patientsAlastair Smith, Nicholas David Robert Denny, Catherine Chahrour, et al.
Aging Cell|June 6, 2022
Accelerated epigenetic aging in newborns with Down syndromeKeren Xu, Shaobo Li, Ivo S Muskens, et al.
The Journal of Clinical Investigation|February 7, 2018
Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translationVijaykumar Chennupati, Diogo Ft Veiga, Kendle M Maslowski, et al.
Nature Communications|November 26, 2021
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression programSiobhan Rice, Thomas Jackson, Nicholas T Crump, et al.
Blood Advances|July 3, 2025
PROM1/CD133 MARKS A PROLIFERATIVE STEM CELL LIKE POPULATION OF BLASTS IN KMT2A REARRANGED INFANT ALLJoe Wilson Cross, Lucy May Field, Alastair Smith, et al.
Leukemia|April 4, 2020
H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cellsLaura Godfrey, Nicholas T Crump, Sorcha O'Byrne, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Genome-wide association studies of Down syndrome associated congenital heart defectsElizabeth R Feldman, Yunqi Li, David J Cutler, et al.
Blood|September 3, 2025
Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemiaHongwei Ren, Natalina Elliott, Bryan Lye, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Blood|June 25, 2025
Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndromeNatalina Elliott, Neha Bhatnagar, Gemma Buck, et al.
Blood|November 22, 2012
Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myelomaAristeidis Chaidos, Chris P Barnes, Gillian Cowan, et al.
Blood|July 29, 2025
Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patientsAlastair Smith, Nicholas David Robert Denny, Catherine Chahrour, et al.
Aging Cell|June 6, 2022
Accelerated epigenetic aging in newborns with Down syndromeKeren Xu, Shaobo Li, Ivo S Muskens, et al.
The Journal of Clinical Investigation|February 7, 2018
Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translationVijaykumar Chennupati, Diogo Ft Veiga, Kendle M Maslowski, et al.
Nature Communications|November 26, 2021
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression programSiobhan Rice, Thomas Jackson, Nicholas T Crump, et al.
Blood Advances|July 3, 2025
PROM1/CD133 MARKS A PROLIFERATIVE STEM CELL LIKE POPULATION OF BLASTS IN KMT2A REARRANGED INFANT ALLJoe Wilson Cross, Lucy May Field, Alastair Smith, et al.
Leukemia|April 4, 2020
H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cellsLaura Godfrey, Nicholas T Crump, Sorcha O'Byrne, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Genome-wide association studies of Down syndrome associated congenital heart defectsElizabeth R Feldman, Yunqi Li, David J Cutler, et al.
Blood|September 3, 2025
Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemiaHongwei Ren, Natalina Elliott, Bryan Lye, et al.
Pageof 13